■ Hematopoietic Cell Transplantation in Japan

Annual Report of Nationwide Survey 2022

Summary Slide

The following slides contained the errors described below. We sincerely apologize for the error.

Original file[Nationwide_Survey_fy2022_sep_vol_20230331_eng_pic.pptx]
Corrected file[Nationwide_Survey_fy2022_sep_vol_20230411_eng_pic.pptx]

Slide
Incorrect /Correct

Slide
Incorrect /Correct

Slide 23
horizontal (X) axis labels

vertical (Y) axis labels(Incorrect)
移植実施年(Incorrect)
高リスク群(Correct)
Year(Correct)
Proportion

割合

Slide 24
horizontal (X) axis labels

vertical (Y) axis labels(Incorrect)
移植実施年(Incorrect)
骨髄非破壊的前治療群(Correct)
Year(Correct)
Proportion割合■ Hematopoietic Cell Transplantation in Japan

Annual Report of Nationwide Survey 2020

Summary Slide

The following slides contained the errors described below. We sincerely apologize for the error.

Original file[Nationwide_Survey_fy2020_sep_vol_20210331_eng_pic.pptx]
Corrected file[Nationwide_Survey_fy2020_sep_vol_20220328_eng_pic.pptx]

Slide

Slide 41
Description about the analysis population in the title bar

Slide 42
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 43
Description about the analysis population in the title bar

Slide 44
Description about the analysis population in the title bar

Slide 45
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <HLA-identical Sibling> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <HLA-identical Sibling> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-BM> (Age≤15)

Slide

Slide 46
Description about the analysis population in the title bar

Slide 47
Description about the analysis population in the title bar

Slide 48
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-CB> (Age≥16)

SlideSlide 49
Description about the analysis population in the title bar

Slide 50
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 51
Description about the analysis population in the title bar

Slide 52
Description about the analysis population in the title bar

Slide 53
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <HLA-identical Sibling> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <HLA-identical Sibling> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-BM> (Age≤15)

Slide

Slide 54
Description about the analysis population in the title bar

Slide 55
Description about the analysis population in the title bar

Slide 56
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-CB> (Age≥16)

Slide

Slide 57
Description about the analysis population in the title bar

Slide 58
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <Allogeneic> (Age≥16)

SlideSlide 59
Description about the analysis population in the title bar

Slide 60
Description about the analysis population in the title bar

Slide 61
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <UR-CB> (Age≥16)

Slide

Slide 62
Description about the analysis population in the title bar

Slide 63
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 64
Description about the analysis population in the title bar

Slide 65
Description about the analysis population in the title bar

Slide 66
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <HLA-identical Sibling> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <HLA-identical Sibling> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-BM> (Age≤15)

Slide

Slide 67
Description about the analysis population in the title bar

Slide 68
Description about the analysis population in the title bar

Slide 69
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-CB> (Age≥16)

SlideSlide 70
Description about the analysis population in the title bar

Slide 71
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 72
Description about the analysis population in the title bar

Slide 73
Description about the analysis population in the title bar

Slide 74
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-BM> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-BM> (Age≥16)

Slide

Slide 75
Description about the analysis population in the title bar

Slide 76
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-CB> (Age≥16)

Slide

Slide 77
Description about the analysis population in the title bar

Slide 78
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Autologous Transplants for MM /PCD, 1991-2019 <Autologous> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MM /PCD, 1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Autologous Transplants for MM /PCD, 2010-2019 <Autologous> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MM /PCD, 2010-2019 <Allogeneic> (Age≥16)

SlideSlide 79
Description about the analysis population in the title bar

Slide 80
Description about the analysis population in the title bar

Slide 81
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Autologous Transplants for MM /PCD, 1991-2019 <Autologous> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MM /PCD, 1991-2019 <Allogeneic> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MM /PCD, 1991-2019 <UR-BM> (Age≥16)(Correct)
Survival after Autologous Transplants for MM /PCD, 2010-2019 <Autologous> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MM /PCD, 2010-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MM /PCD, 2010-2019 <UR-BM> (Age≥16)

Slide

Slide 82
Description about the analysis population in the title bar

Slide 83
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AA,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AA, 19912019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AA,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AA, 20102019 <Allogeneic> (Age≥16)

Slide

Slide 84
Description about the analysis population in the title bar

Slide 85
Description about the analysis population in the title bar

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AA,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AA, 19912019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AA,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AA, 20102019 <Allogeneic> (Age≥16)

■ Hematopoietic Cell Transplantation in Japan Annual Report of Nationwide Survey 2020 Summary Slide-Appendix to slide 34-85 : The number of patients in each group and crude survival probabilitiesThe appedix contained the errors described below. We sincerely apologize for the error.

Original file
[Appendix_Table_OS_2020_20210325.pdf]
Corrected file
[Appendix_Table_OS_2020_20220118.pdf]

Slide

Slide 41
Description about the analysis population

Slide 42
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 43
Description about the analysis population

Slide 44
Description about the analysis population

Slide 45
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <HLA-identical Sibling> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <HLA-identical Sibling> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-BM> (Age≤15)

Slide

Slide 46
Description about the analysis population

Slide 47
Description about the analysis population

Slide 48
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AML,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AML,
2010-2019 <UR-CB> (Age≥16)

SlideSlide 49
Description about the analysis population

Slide 50
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 51
Description about the analysis population

Slide 52
Description about the analysis population

Slide 53
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <HLA-identical Sibling> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <HLA-identical Sibling> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-BM> (Age≤15)

Slide

Slide 54
Description about the analysis population

Slide 55
Description about the analysis population

Slide 56
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for ALL,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for ALL,
2010-2019 <UR-CB> (Age≥16)

Slide

Slide 57
Description about the analysis population

Slide 58
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <Allogeneic> (Age≥16)

SlideSlide 59
Description about the analysis population

Slide 60
Description about the analysis population

Slide 61

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for CML,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for CML,
2010-2019 <UR-CB> (Age≥16)

Slide

Slide 62
Description about the analysis population

Slide 63
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 64
Description about the analysis population

Slide 65
Description about the analysis population

Slide 66
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <HLA-identical Sibling> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <HLA-identical Sibling> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-BM> (Age≤15)

Slide

Slide 67
Description about the analysis population

Slide 68
Description about the analysis population

Slide 69
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-BM> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for MDS,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for MDS,
2010-2019 <UR-CB> (Age≥16)

Description about the analysis population

SlideSlide 70
Description about the analysis population

Slide 71
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <Allogeneic> (Age≥16)

Slide

Slide 72
Description about the analysis population

Slide 73
Description about the analysis population

Slide 74
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <HLA-identical Sibling> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-BM> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-BM> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <HLA-identical Sibling> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-BM> (Age≤15)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-BM> (Age≥16)

Slide

Slide 75
Description about the analysis population

Slide 76
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-CB> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for NHL,
1991-2019 <UR-CB> (Age≥16)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-CB> (Age≤15)(Correct)
Survival after Allogeneic Transplants for NHL,
2010-2019 <UR-CB> (Age≥16)

Slide

Slide 77
Description about the analysis population

Slide 78
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Autologous Transplants for MM /PCD, 1991-2019 <Autologous> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MM /PCD, 1991-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Autologous Transplants for MM /PCD, 2010-2019 <Autologous> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MM /PCD, 2010-2019 <Allogeneic> (Age≥16)

SlideSlide 79
Description about the analysis population

Slide 80
Description about the analysis population

Slide 81
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Autologous Transplants for MM /PCD, 1991-2019 <Autologous> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MM /PCD, 1991-2019 <Allogeneic> (Age≥16)(Incorrect)
Survival after Allogeneic Transplants for MM /PCD, 1991-2019 <UR-BM> (Age≥16)(Correct)
Survival after Autologous Transplants for MM /PCD, 2010-2019 <Autologous> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MM /PCD, 2010-2019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for MM /PCD, 2010-2019 <UR-BM> (Age≥16)

Slide

Slide 82
Description about the analysis population

Slide 83
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AA,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AA, 19912019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AA,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AA, 20102019 <Allogeneic> (Age≥16)

Slide

Slide 84
Description about the analysis population

Slide 85
Description about the analysis population

Incorrect /Correct(Incorrect)
Survival after Allogeneic Transplants for AA,
1991-2019 <Allogeneic> (Age≤15)(Incorrect)
Survival after Allogeneic Transplants for AA, 19912019 <Allogeneic> (Age≥16)(Correct)
Survival after Allogeneic Transplants for AA,
2010-2019 <Allogeneic> (Age≤15)(Correct)
Survival after Allogeneic Transplants for AA, 20102019 <Allogeneic> (Age≥16)

■ Activities and Outcomes of Hematopoietic Cell Transplantation in Japan

Summary Slide

The following slides contained the errors described below. We sincerely apologize for the error.

Slide
Incorrect / Correct

Activities and Outcomes of
Hematopoietic Cell
Transplantation in Japan (2015)

Activities and Outcomes of
Hematopoietic Cell
Transplantation in Japan (2016)

Activities and Outcomes of
Hematopoietic Cell
Transplantation in Japan (2017)

Activities and Outcomes of
Hematopoietic Cell
Transplantation in Japan (2018)

Activities and Outcomes of
Hematopoietic Cell
Transplantation in Japan (2019)

Slide 8, Slide 9
Indications for hematopoietic
stem cell transplants

Slide 9, Slide 10
Indications for hematopoietic
stem cell transplants

Slide 9, Slide 10
Indications for hematopoietic
stem cell transplants

Slide 9, Slide 10
Indications for hematopoietic
stem cell transplants

Slide 9, Slide 10
Indications for hematopoietic
stem cell transplants

Description in the title bar

Description in the title bar

Description in the title bar

Description in the title bar

Description in the title bar(Incorrect)
Indications for Hematopoetic
Stam Cell Transplants in 19912014(Incorrect)
Indications for Hematopoetic
Stam Cell Transplants in 19912015(Incorrect)
Indications for Hematopoetic
Stam Cell Transplants in 19912016(Incorrect)
Indications for Hematopoetic
Stam Cell Transplants in 19912017(Incorrect)
Indications for Hematopoetic
Stam Cell Transplants in 19912018(Correct)
Indications for Hematopoetic
Stam Cell Transplants in 19742014(Correct)
Indications for Hematopoetic
Stam Cell Transplants in 19742015(Correct)
Indications for Hematopoetic
Stam Cell Transplants in 19742016(Correct)
Indications for Hematopoetic
Stam Cell Transplants in 19742017(Correct)
Indications for Hematopoetic
Stam Cell Transplants in 19742018